Cargando…

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy

Recently, telemedicine has become remarkably important, due to increased deployment and development of digital technologies. National and international guidelines should consider its inclusion in their updates. During the COVID-19 pandemic, mandatory social distancing and the lack of effective treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galiero, Raffaele, Pafundi, Pia Clara, Nevola, Riccardo, Rinaldi, Luca, Acierno, Carlo, Caturano, Alfredo, Salvatore, Teresa, Adinolfi, Luigi Elio, Costagliola, Ciro, Sasso, Ferdinando Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584941/ https://www.ncbi.nlm.nih.gov/pubmed/33123599 http://dx.doi.org/10.1155/2020/9036847

Ejemplares similares

Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
por: Rinaldi, Luca, et al.
Publicado: (2021)

The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
por: Salvatore, Teresa, et al.
Publicado: (2021)

Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2021)

Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies
por: Vetrano, Erica, et al.
Publicado: (2023)

Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects
por: Pafundi, Pia Clara, et al.
Publicado: (2021)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
por: Caturano, Alfredo, et al.
Publicado: (2019)

Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
por: Palmiero, Giuseppe, et al.
Publicado: (2021)

Metformin: A Potential Therapeutic Tool for Rheumatologists
por: Salvatore, Teresa, et al.
Publicado: (2020)

Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?
por: Salvatore, Teresa, et al.
Publicado: (2020)

HCC and Molecular Targeting Therapies: Back to the Future
por: Rinaldi, Luca, et al.
Publicado: (2021)

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2022)

Incretin Hormones: The Link between Glycemic Index and Cardiometabolic Diseases
por: Salvatore, Teresa, et al.
Publicado: (2019)

Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2018)

Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study
por: Caturano, Alfredo, et al.
Publicado: (2023)

Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations
por: Galiero, Raffaele, et al.
Publicado: (2023)

Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2019)

Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
por: Salvatore, Teresa, et al.
Publicado: (2021)

GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives
por: Nevola, Riccardo, et al.
Publicado: (2023)

The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia
por: Galiero, Raffaele, et al.
Publicado: (2022)

Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis
por: Cuomo, Giovanna, et al.
Publicado: (2023)

Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
por: Salvatore, Teresa, et al.
Publicado: (2021)

Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study
por: Caturano, Alfredo, et al.
Publicado: (2023)

Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals
por: Nevola, Riccardo, et al.
Publicado: (2020)

Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome
por: Cozzolino, Domenico, et al.
Publicado: (2023)

Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study
por: Galiero, Raffaele, et al.
Publicado: (2020)

Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study
por: Pafundi, Pia Clara, et al.
Publicado: (2021)

Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes
por: Salvatore, Teresa, et al.
Publicado: (2022)

Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes
por: Salvatore, Teresa, et al.
Publicado: (2022)

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
por: Salvatore, Teresa, et al.
Publicado: (2022)

Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications
por: Caturano, Alfredo, et al.
Publicado: (2023)

Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options
por: Salvatore, Teresa, et al.
Publicado: (2022)

Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study
por: Rinaldi, Luca, et al.
Publicado: (2019)

Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
por: Adinolfi, Luigi Elio, et al.
Publicado: (2018)

Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics
por: Rinaldi, Luca, et al.
Publicado: (2020)

Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19
por: Messina, Vincenzo, et al.
Publicado: (2022)

Predictors of early and late hepatocellular carcinoma recurrence
por: Nevola, Riccardo, et al.
Publicado: (2023)

Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination
por: Nevola, Riccardo, et al.
Publicado: (2023)

Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options
por: Galiero, Raffaele, et al.
Publicado: (2023)

Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience
por: Attena, Emilio, et al.
Publicado: (2023)

Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world study
por: Nevola, Riccardo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3m4k32ppf9gmg4b87ajm5leqrb